Yantai Dongcheng Pharmaceutical Group Co.,Ltd.
002675.SZ · SHZ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | CN¥141,425 | CN¥209,736 | CN¥352,816 | CN¥260,850 |
| Dep. & Amort. | CN¥174,478 | CN¥147,246 | CN¥125,093 | CN¥114,931 |
| Deferred Tax | CN¥0 | CN¥0 | -CN¥3,337 | -CN¥5,918 |
| Stock-Based Comp. | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| Change in WC | -CN¥318,957 | -CN¥279,584 | CN¥191,260 | CN¥311,164 |
| Other Non-Cash | CN¥290,205 | CN¥199,547 | CN¥327,368 | CN¥256,636 |
| Operating Cash Flow | CN¥287,151 | CN¥276,945 | CN¥996,537 | CN¥943,581 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -CN¥456,094 | -CN¥511,945 | -CN¥389,612 | -CN¥530,158 |
| Net Acquisitions | -CN¥3,456 | -CN¥201,109 | CN¥33 | CN¥287 |
| Inv. Purchases | -CN¥1,086,718 | -CN¥290,771 | -CN¥560,706 | -CN¥1,390,314 |
| Inv. Sales/Matur. | CN¥828,907 | CN¥398,636 | CN¥495,885 | CN¥1,180,938 |
| Other Inv. Act. | CN¥2,363 | CN¥2,388 | CN¥1,651 | CN¥0 |
| Investing Cash Flow | -CN¥714,998 | -CN¥602,801 | -CN¥452,748 | -CN¥739,246 |
| Financing Activities | – | – | – | – |
| Debt Repay. | CN¥87,269 | CN¥98,159 | -CN¥387,800 | CN¥48,518 |
| Stock Issued | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| Stock Repurch. | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| Dividends Paid | -CN¥217,253 | -CN¥258,335 | -CN¥251,238 | -CN¥302,475 |
| Other Fin. Act. | CN¥673,565 | CN¥159,500 | CN¥278,176 | CN¥65,275 |
| Financing Cash Flow | CN¥543,581 | -CN¥676 | -CN¥359,126 | -CN¥188,682 |
| Forex Effect | CN¥12,149 | CN¥7,420 | CN¥6,264 | CN¥6,749 |
| Net Chg. in Cash | CN¥127,882 | -CN¥319,113 | CN¥190,926 | CN¥22,402 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | CN¥607,738 | CN¥926,851 | CN¥735,924 | CN¥713,522 |
| End Cash | CN¥735,621 | CN¥607,738 | CN¥926,851 | CN¥735,924 |
| Free Cash Flow | -CN¥168,943 | -CN¥235,001 | CN¥606,925 | CN¥413,424 |